IORD presents May 2025 rare disease breakthroughs, showcasing advances in AI-based diagnostics, CRISPR therapies, and genetic testing, signaling improved detection, treatment, and global progress in care.
Classic Blog Right Sidebar
- Classic Blog Right Sidebar
- Grid Right Sidebar
- Grid Left Sidebar
- Masonry 3 columns
- Masonry 2 columns
- Masonry 4 Columns
- Grid 2 Columns
- Grid 3 Columns
- Grid 4 Columns
- Masonry Left Sidebar
- Masonry Right Sidebar
- Multi Author Right Sidebar
- Multi Author Left Sidebar
- Multi Author Layout
- Masonry Full Width
- Grid Full Width
The World Health Assembly adopted a historic rare diseases resolution, with India among co-sponsors, approving a 10-year global plan for equitable care, policy action, and inclusion.
IORD highlights India’s rare disease crisis, with Prof. Ramaiah Muthyala urging grassroots solutions to improve access, awareness, and care for millions affected nationwide.
IORD CEO & President Dr. Ramaiah Muthyala provides insights on advancing rare disease awareness in India, stressing early diagnosis, frontline healthcare training, and integration into public health systems.
IORD highlights gaps in rare disease care, with Prof. Ramaiah Muthyala noting progress under NPRD but stressing persistent challenges in diagnosis, treatment, and need for disease-specific strategies.